Supriya Lifescience Limited (SUPRIYA.BO)
INR 756.75
(-0.05%)
INR 756.75
(-0.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.57 Billion INR | 36.0% |
| 2022 | 1.15 Billion INR | -42.36% |
| 2021 | 2 Billion INR | 21.61% |
| 2020 | 1.64 Billion INR | 76.01% |
| 2019 | 936.62 Million INR | 53.02% |
| 2018 | 612.07 Million INR | 266.71% |
| 2017 | 166.91 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 578.86 Million INR | 12.2% |
| 2024 Q2 | 599.73 Million INR | 3.61% |
| 2023 Q2 | 277.71 Million INR | -31.49% |
| 2023 Q1 | 405.37 Million INR | -22.1% |
| 2023 Q4 | 515.9 Million INR | 37.47% |
| 2023 FY | 1.57 Billion INR | 36.0% |
| 2023 Q3 | 375.29 Million INR | 35.14% |
| 2022 Q4 | 520.38 Million INR | 369.06% |
| 2022 Q3 | 110.94 Million INR | -77.16% |
| 2022 Q2 | 485.69 Million INR | 71.26% |
| 2022 Q1 | 283.6 Million INR | -60.96% |
| 2022 FY | 1.15 Billion INR | -42.36% |
| 2021 Q1 | 149.15 Million INR | -77.19% |
| 2021 FY | 2 Billion INR | 21.61% |
| 2021 Q4 | 726.44 Million INR | 103.05% |
| 2021 Q3 | 357.77 Million INR | -62.2% |
| 2021 Q2 | 946.41 Million INR | 534.54% |
| 2020 Q3 | 253.67 Million INR | 0.0% |
| 2020 FY | 1.64 Billion INR | 76.01% |
| 2020 Q4 | 653.82 Million INR | 157.74% |
| 2019 FY | 936.62 Million INR | 53.02% |
| 2018 FY | 612.07 Million INR | 266.71% |
| 2017 FY | 166.91 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 9.28 Million INR | -16830.41% |
| Biocon Limited | 50.83 Billion INR | 96.908% |
| Blue Jet Healthcare Limited | 3.37 Billion INR | 53.394% |
| Concord Biotech Limited | 6.26 Billion INR | 74.901% |
| Dishman Carbogen Amcis Limited | -13.9 Million INR | 11406.835% |
| FERMENTA BIOTECH LIMITED | 1.06 Billion INR | -47.166% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.27 Million INR | -123094.199% |
| Lyka Labs Limited | 29.13 Million INR | -5295.297% |
| Panacea Biotec Limited | -309.7 Million INR | 607.475% |
| SAMSRITA LABS LIMITED | -1.49 Million INR | 105059.997% |
| Servoteach Industries Limited | -785.00 INR | 200210291.083% |
| SMS Lifesciences India Limited | 359.47 Million INR | -337.211% |
| Syngene International Limited | 14.02 Billion INR | 88.794% |
| TAKE Solutions Limited | -213.49 Million INR | 836.17% |
| Titan Biotech Limited | 315.89 Million INR | -397.518% |
| Transgene Biotek Limited | -7.08 Million INR | 22270.264% |
| Vanta Bioscience Limited | -31.83 Million INR | 5036.397% |